Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of hyperandrogenic conditions

Treatment of hyperandrogenic conditions

US Patent 5656613 · Granted Aug 12, 1997

Estimated economic value: $120,741,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Toxoplasma gondii cylclic GMP dependent protein kinase G as a chemotherapeutic t2010
Cyclic GMP dependent protein kinase as a chemotherapeutic target for antiprotozo2006
Polynucleotide encoding eimeria tenella cGMP dependent protein kinase2003
Method of improving in-vitro fertilization2002
Irreversible inhibition of human 5.alpha.-reductase1999
Irreversible inhibition of human 5.alpha.-reductase1999
Methods for treating polycystic ovary syndrome1999
Treatment of hyperandrogenic conditions1999
Treatment of hyperandrogenic conditions1999
17-alkyl-7-substituted-4-aza steroid derivatives as 5-.alpha.-reductase inhibito1998
Treatment of hyperandrogenic conditions1998
Treatment of hyperandrogenic conditions1998